Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle
- 11 September 2003
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 18 (10) , 879-886
- https://doi.org/10.1002/gps.928
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Practice effects on cognitive tasks: a major problem?The Lancet Neurology, 2002
- Goal setting and attainment in Alzheimer's disease patients treated with donepezilJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Testing cognitive function in elderly populations: the PROSPER studyJournal of Neurology, Neurosurgery & Psychiatry, 2002
- How to define treatment success using cholinesterase inhibitorsInternational Journal of Geriatric Psychiatry, 2002
- Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with DonepezilCurrent Medical Research and Opinion, 2002
- Donepezil for Alzheimer's Disease: Pharmacodynamic, Pharmacokinetic, and Clinical ProfilesCNS Drug Reviews, 2001
- The effects of practice on measures of performanceHuman Psychopharmacology: Clinical and Experimental, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- “Mini-mental state”Journal of Psychiatric Research, 1975